← Back to all products
Tirzepatide
10mg/vial · Dual GIP/GLP-1 Agonist
฿2,300
Purity >98%Keep RefrigeratedResearch Use Only
About this peptide
Tirzepatide is a dual GIP and GLP-1 receptor agonist that demonstrated up to 22.5% weight reduction in the SURMOUNT clinical trials. Marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, it combines complementary metabolic pathways for superior efficacy over single-receptor agonists — a benchmark peptide for obesity and metabolic research.
⚠️ For research use only.